In response to the global spread of antimicrobial resistance, there is an increased demand
for novel and innovative antimicrobials. Bacteriophages have been known for their potential …

Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections
and contributes to significant increase in morbidity and mortality especially when associated …

Phage therapy has gained attention due to the spread of antibiotic-resistant bacteria and
narrow pipeline of novel antibiotics. Phage cocktails are hypothesized to slow the overall …

Bacterial antibiotic resistance, especially the emergence of multidrug-resistant (MDR)
strains, urgently requires the development of effective treatment strategies. It is always of …

Biofilm-producing Pseudomonas aeruginosa infections pose a severe threat to public health
and are responsible for high morbidity and mortality. Phage-antibiotic combinations (PACs) …

Phage-antibiotic combinations to treat bacterial infections are gaining increased attention
due to the synergistic effects often observed when applying both components together. Most …

Methicillin-resistant Staphylococcus aureus (MRSA) causes biofilm-related medical device
infections. Phage-antibiotic combinations offer potential therapy due to proven in vitro …

Apart from antibiotic resistance of pathogenic bacteria, the formation of biofilms is a feature
that makes bacterial infections especially difficulty to treat. Shiga toxin-producing …

Drug-resistant Staphylococcus aureus stands as a prominent pathogen in nosocomial and
community-acquired infections, capable of inciting various infections at different sites in …

Introduction Staphylococcus aureus (S. aureus) is a common pathogen that frequently
colonizes the sinonasal cavity. Recent studies demonstrated the essential role of …